Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma. - Wikidata - awgldk - TriplyDB

Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma.

Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma.

http://www.wikidata.org/entity/Q46092312

about

Immunotherapy strategies for multiple myeloma: the present and the future Novel immunotherapies Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients.Progress on new vaccine strategies for the immunotherapy and prevention of cancer.Vaccine therapy of B cell malignancies: different strategies for a novel approach.Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.Strategies for designing and optimizing new generation vaccines.Dendritic cell-based immunotherapy for the treatment of hematological malignancies.Cellular immunotherapy after autologous hematopoietic stem cell transplantation: experimental strategies and clinical experiences.Immunotherapy in multiple myeloma: current strategies and future prospects.Dendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression?Dendritic cells and their potential therapeutic role in haematological malignancy.Clonal cytotoxic T cells in myeloma.Dendritic cell-based immunotherapy in multiple myeloma.Molecular monitoring of minimal residual disease in patients with multiple myeloma.Stem cell transplantation for multiple myeloma.Optimizing immunotherapy in multiple myeloma: Restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells Immunotherapy using dendritic cells against multiple myeloma: how to improve?Cellular immunotherapy using dendritic cells against multiple myeloma NY-ESO-1 immunotherapy for multiple myeloma.Immunotherapy of multiple myeloma: the start of a long and tortuous journey.Advances in immunotherapy of multiple myeloma: from the discovery of tumor-associated antigens to clinical trials.Roles of idiotype-specific t cells in myeloma cell growth and survival: Th1 and CTL cells are tumoricidal while Th2 cells promote tumor growth.Immune therapies.CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma Double autologous stem cell transplantation for multiple myeloma: a Korean single center study.Drug-mediated and cellular immunotherapy in multiple myeloma.Developing dendritic cell-based therapies to condition immune responses to novel oncogenic proteins and stem cells.Targeting multiple-myeloma-induced immune dysfunction to improve immunotherapy outcomes.Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.Evolution of cellular immunotherapy: from allogeneic transplant to dendritic cell vaccination as treatment for multiple myeloma.Immunotherapeutic approaches to treat multiple myeloma Immunotherapy for multiple myeloma.Beyond consolidation: auto-SCT and immunotherapy for plasma cell myeloma.Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity.Dendritic Cell Therapies for Hematologic Malignancies.Targeted idiotype-fusion DNA vaccines for human multiple myeloma: preclinical testing.Growth inhibition of myeloma cells by anti-idiotype antibodies in the absence of membrane-bound immunoglobulin.Etoposide (VP-16) plus G-CSF mobilizes different dendritic cell subsets than does G-CSF alone.Results of a Phase II clinical trial with Id-protein-loaded dendritic cell vaccine in multiple myeloma: encouraging or discouraging?

P2860

Q27021939-90764F98-1FDF-4935-879A-ECBB54D1D63E Q33822677-80727E35-C1EE-4D6D-B4C0-122828462436 Q34075717-8354500B-7C8D-4F6A-B099-712322A91B7E Q34328457-FEF58BBE-D4CA-47F3-AA77-D4AC42ED5196 Q34430359-00D854F9-D7F9-4762-8AD0-EE277072FF78 Q34487409-6BACB779-E0ED-404B-AC9C-B8623C487381 Q34572198-1DB74854-58B7-4ED4-96C9-CA16D4EC442F Q35127001-D708007B-DA54-4468-8BBD-A989CCA0ECE8 Q35137164-F02B2AB3-4BD6-41CF-B998-2C76C6156ED1 Q35194182-3B1BBB2C-0CE6-4EBF-ADFE-8B86CBB7F99F Q35584599-540B00B2-EC57-4132-AD12-1911456A4C51 Q35614625-59F28E64-EA8C-4DAB-A130-231F470FD036 Q35614630-FF79B685-6F37-48D4-AE67-42AE55A0B735 Q35665926-EA8E0BA5-782A-4E07-AEB1-10911C616F80 Q35668677-DC89B2C1-6244-4C2E-8B1F-C1337B5B8BEB Q35692626-FCE3E763-2469-4A80-BA22-C7A7966287FB Q35848756-6630AD0D-5CE9-4751-8155-B774B29675F5 Q35852574-02AC4599-09FD-462B-9749-B3274F257749 Q35865581-60B0C44D-DC62-47C9-8287-13274FA90BAE Q36637651-AF4E5DF8-38E0-4AFD-9825-FD5AD1918DBB Q36689152-A11925DF-7151-44A0-921C-95D91558E129 Q36844954-2D4DBE08-A6C5-47B1-92D9-22712D282AAF Q36955402-BC7DE7AF-ED5C-42F5-9046-31F955C1416B Q36998232-4E829DB6-4CC2-4BB7-AEDF-C2F4AC2BCCAE Q37260574-7D140589-69FC-444F-AC14-509B54CCA464 Q37476203-55088639-B851-4B54-8645-FF493275407D Q37773257-C547BDF5-DDC9-41AF-9B4C-9E6DF4446179 Q37960189-7AB5054B-1321-4EA2-9774-370CEE2FB602 Q38008379-4D731C01-0A01-4D91-8426-FFF18FFF114C Q38014834-291C55AC-6EA4-448A-8039-AF598F645505 Q38059517-B9CEDB27-26BD-42B7-800C-9860753A95EF Q38171067-D44B77C6-4085-4EAF-95FA-4D08DE7C734C Q38177879-A8C31C72-22BD-406A-AE1C-1A2F472C81A7 Q38370539-B27E31F8-6353-4D0D-8E21-87E25D73111A Q39265240-7FE52F2C-0EC6-4918-951F-BA819F0D6A39 Q39289930-BCF26798-3F8B-45D3-AC14-D98202B2B99E Q39589735-94AA4DA2-3009-491B-AAB0-93FC02C27306 Q40025045-307BCF9B-7954-469B-B75A-E1324F972E00 Q44351329-472F5823-8087-41D1-89CC-8952A3A16E6A Q47562358-B5781446-38B0-406F-A924-C3FB6FE6904B

P2860

Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma.

http://www.wikidata.org/entity/Q46092312

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

2000年學術文章

@zh-hant

name

Idiotype vaccination using den ...... antation for multiple myeloma.

@en

Idiotype vaccination using den ...... antation for multiple myeloma.

@nl

type

label

Idiotype vaccination using den ...... antation for multiple myeloma.

@en

Idiotype vaccination using den ...... antation for multiple myeloma.

@nl

prefLabel

Idiotype vaccination using den ...... antation for multiple myeloma.

@en

Idiotype vaccination using den ...... antation for multiple myeloma.

@nl

P1433

Q46092312-2C138603-3DAA-4FC4-AEDB-0F9E8009ADCE

P1476

Q46092312-8A5A9DE8-A43E-4214-AA6A-D283B6943F9D

P2093

Q46092312-00FD2DE4-E97D-41C8-A3EE-E0F272D240F6

Q46092312-0716F3D1-E118-4E8E-94BB-197AC9A96416

Q46092312-10D3544E-A6E2-4EBE-95D5-5E71DBFEB946

Q46092312-3E79318C-EC7F-42DE-900E-8DDA0F80D366

Q46092312-5F9FF35A-EB3F-4E81-936A-0F8E8095F3D2

Q46092312-6A70C44F-4E90-424E-BA29-4486D8539D56

Q46092312-869AB529-ED91-4C34-A353-261B903741CF

Q46092312-A45AB44A-3336-49A8-BDE3-3815550381E4

Q46092312-B83C46DE-D9A1-4983-8035-656C062049E3

Q46092312-F961DCA3-1668-4A96-94FA-53A1F01640D2

P304

Q46092312-BC5C230F-7656-4B64-BF22-7E3AD514C5D0

P31

Q46092312-E4AF4B00-52D0-4DE5-8CC4-6AB660CA4034

P356

Q46092312-51DF5063-94AF-44C0-93D4-89FCCC057EBC

P433

Q46092312-B6AE9557-DD23-4E64-8A66-DB2C98696FF7

P478

Q46092312-EB53EC23-90B3-440D-94AA-4A35D11CE278

P577

Q46092312-ADB30851-99AE-4B83-826C-71FA4CCB014D

P698

Q46092312-52EE808D-1EC3-4518-BD37-D31AFBBF3496

P356

S1083-8791(00)70027-9

P1433

Biology of Blood and Marrow Transplantation

P1476

Idiotype vaccination using den ...... antation for multiple myeloma.

@en

P2093

Auffermann-Gretzinger S

http://www.w3.org/2001/XMLSchema#string

Benike CJ

http://www.w3.org/2001/XMLSchema#string

Blume KG

http://www.w3.org/2001/XMLSchema#string

Engleman EG

http://www.w3.org/2001/XMLSchema#string

Levy R

http://www.w3.org/2001/XMLSchema#string

Liso A

http://www.w3.org/2001/XMLSchema#string

Rajapaksa R

http://www.w3.org/2001/XMLSchema#string

Reichardt V

http://www.w3.org/2001/XMLSchema#string

Stockerl-Goldstein KE

http://www.w3.org/2001/XMLSchema#string

van Beckhoven A

http://www.w3.org/2001/XMLSchema#string

P304

621-627

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1083-8791(00)70027-9

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2000-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11128812

http://www.w3.org/2001/XMLSchema#string